UBS Starts MiniMed Group (MMED) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts MMED Hot Sheet
Price: $17.49 -2.83%
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 41
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 41
Join SI Premium – FREE
UBS initiates coverage on MiniMed Group (NASDAQ: MMED) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on MiniMed Group click here. For more ratings news on MiniMed Group click here.
Shares of MiniMed Group closed at $17.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Federal Bank Ltd (FB:IN) PT Lowered to INR400 at UBS
- DLF Ltd. (DLFU:IN) PT Raised to INR830 at Jefferies
- HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Lowered to INR3,050 at Nomura/Instinet
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBS, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
